Compare PNW & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNW | ELAN |
|---|---|---|
| Founded | 1985 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.7B |
| IPO Year | 1994 | 2018 |
| Metric | PNW | ELAN |
|---|---|---|
| Price | $100.12 | $21.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $100.21 | $27.89 |
| AVG Volume (30 Days) | 867.4K | ★ 4.8M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.27 | 0.11 |
| Revenue | ★ $5,339,939,000.00 | $4,715,000,000.00 |
| Revenue This Year | $5.15 | $8.21 |
| Revenue Next Year | $6.89 | $5.31 |
| P/E Ratio | $369.70 | ★ $198.41 |
| Revenue Growth | 4.20 | ★ 6.22 |
| 52 Week Low | $85.32 | $12.40 |
| 52 Week High | $104.92 | $27.72 |
| Indicator | PNW | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 42.51 |
| Support Level | $99.88 | $20.65 |
| Resistance Level | $104.34 | $22.81 |
| Average True Range (ATR) | 1.65 | 1.23 |
| MACD | -0.43 | -0.02 |
| Stochastic Oscillator | 19.21 | 10.26 |
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.